| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2971147 | The Journal of Heart and Lung Transplantation | 2011 | 7 Pages |
Abstract
A genetic predisposition to elevated IFN-γ levels may play a dual role in controlling active CMV infection among lung transplant recipients receiving alemtuzumab induction and valganciclovir prophylaxis, limiting the extent of viral replication in serum but increasing the risk of CMV disease.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Dimitra MD, M. Hong Nguyen, Diana M. Girnita, Kathleen Spichty, Eun J. Kwak, Fernanda P. Silveira, Yoshiya Toyoda, Joseph M. Pilewski, Maria Crespo, Jay K. Bhama, Rima Abdel-Massih, Diana Zaldonis, Adriana Zeevi, Cornelius J. MD,